-
N-[(1R,3R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazole-1-carboxamide hydrate hydrochloride
-
ChemBase ID:
154634
-
Molecular Formular:
C19H29ClN4O3
-
Molecular Mass:
396.91156
-
Monoisotopic Mass:
396.19281849
-
SMILES and InChIs
SMILES:
CC(C)n1c2ccccc2n(c1=O)C(=O)N[C@H]1C[C@H]2CC[C@@H](C1)N2C.O.Cl
Canonical SMILES:
CN1[C@@H]2CC[C@H]1C[C@H](C2)NC(=O)n1c(=O)n(c2c1cccc2)C(C)C.O.Cl
InChI:
InChI=1S/C19H26N4O2.ClH.H2O/c1-12(2)22-16-6-4-5-7-17(16)23(19(22)25)18(24)20-13-10-14-8-9-15(11-13)21(14)3;;/h4-7,12-15H,8-11H2,1-3H3,(H,20,24);1H;1H2/t13-,14+,15-;;
InChIKey:
HZJJVFOOACXPTH-XZAJHMFNSA-N
-
Cite this record
CBID:154634 http://www.chembase.cn/molecule-154634.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
N-[(1R,3R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazole-1-carboxamide hydrate hydrochloride
|
|
|
IUPAC Traditional name
|
3-isopropyl-N-[(1R,3R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxo-1,3-benzodiazole-1-carboxamide hydrate hydrochloride
|
|
|
Synonyms
|
2,3-Dihydro-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-3-(1-methylethyl)-2-oxo-1H-benzimidazole-1-carboxamide Hydrochloride (1:1) hydrate
|
BIMU8 hydrate
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
15.286645
|
H Acceptors
|
3
|
H Donor
|
1
|
LogD (pH = 5.5)
|
-1.435694
|
LogD (pH = 7.4)
|
0.05255055
|
Log P
|
1.854125
|
Molar Refractivity
|
95.9691 cm3
|
Polarizability
|
37.13273 Å3
|
Polar Surface Area
|
55.89 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
B4063
|
Biochem/physiol Actions BIMU8 hydrate is a potent 5-HT4 serotonin receptor agonist. Serotonin (5-HT) is a major neurotransmitter that acts through a family of GPCRs and one ion channel. 5-HT4 receptor is GPCR expressed in many tissues, including brain, and modulates dopamine secretion, learning, and memory. BIMU8 is a full agonist at 5-HT4, but it binds differently than the endogenous ligand, 5-HT, shown through site-directed mutagenesis studies. It depolarizes neurons and was used to localize 5-HT4 to somatic but not dendritic regions of CA1 pyramidal neurons. |
PATENTS
PATENTS
PubChem Patent
Google Patent